Brian Magnuson

3.7k total citations · 1 hit paper
37 papers, 2.3k citations indexed

About

Brian Magnuson is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brian Magnuson has authored 37 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brian Magnuson's work include RNA Research and Splicing (10 papers), DNA Repair Mechanisms (7 papers) and RNA modifications and cancer (7 papers). Brian Magnuson is often cited by papers focused on RNA Research and Splicing (10 papers), DNA Repair Mechanisms (7 papers) and RNA modifications and cancer (7 papers). Brian Magnuson collaborates with scholars based in United States, Slovakia and Sweden. Brian Magnuson's co-authors include Diane C. Fingar, Mats Ljungman, Billy Tsai, Michelle T. Paulsen, Thomas E. Wilson, Artur Veloso, Killeen S. Kirkconnell, Karan Bedi, Michael J. Imperiale and Jonathan Low and has published in prestigious journals such as Nature Communications, Nature Genetics and Blood.

In The Last Decade

Brian Magnuson

36 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks

2011 777 citations Brian Magnuson, Diane C. Fingar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Magnuson United States	18	1.6k	440	237	223	221	37	2.3k
Nicolas Gévry Canada	25	1.9k 1.1×	562 1.3×	234 1.0×	98 0.4×	161 0.7×	52	2.6k
Jorrit M. Enserink Norway	23	2.0k 1.3×	379 0.9×	183 0.8×	411 1.8×	87 0.4×	57	2.6k
Gabriella Minchiotti Italy	34	2.3k 1.4×	337 0.8×	378 1.6×	328 1.5×	113 0.5×	81	3.0k
Nazanine Modjtahedi France	24	1.6k 1.0×	629 1.4×	228 1.0×	348 1.6×	341 1.5×	45	2.6k
Ashwini Jambhekar United States	19	2.5k 1.5×	465 1.1×	599 2.5×	230 1.0×	115 0.5×	37	2.9k
Oleg Denisenko United States	24	1.9k 1.1×	190 0.4×	261 1.1×	159 0.7×	131 0.6×	54	2.4k
Margarida Ruas United Kingdom	26	1.3k 0.8×	612 1.4×	189 0.8×	518 2.3×	284 1.3×	34	3.5k
Diego Miranda‐Saavedra United Kingdom	28	1.8k 1.1×	401 0.9×	175 0.7×	317 1.4×	348 1.6×	43	2.8k
Michael E. Rothenberg United States	19	1.4k 0.8×	378 0.9×	249 1.1×	294 1.3×	108 0.5×	35	2.2k
Kasirajan Ayyanathan United States	18	2.2k 1.4×	315 0.7×	218 0.9×	114 0.5×	118 0.5×	36	2.7k

Countries citing papers authored by Brian Magnuson

Since Specialization

Citations

This map shows the geographic impact of Brian Magnuson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Magnuson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Magnuson more than expected).

Fields of papers citing papers by Brian Magnuson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Magnuson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Magnuson. The network helps show where Brian Magnuson may publish in the future.

Co-authorship network of co-authors of Brian Magnuson

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Magnuson. A scholar is included among the top collaborators of Brian Magnuson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Magnuson. Brian Magnuson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Elaine, Ting Fu, Ling Zhang, et al.. (2025). Genetic variants affecting RNA stability influence complex traits and disease risk. Nature Genetics. 57(10). 2578–2588.

Sharma, Monika, Carlos E. Espinoza, Varunkumar Krishnamoorthy, et al.. (2023). Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence. Molecular Cancer Therapeutics. 23(1). 24–34. 4 indexed citations

Liu, Yiran E., Qing Wang, Nicholas Kunnath, et al.. (2023). Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress. Blood. 142(25). 2159–2174. 3 indexed citations

Li, Shang, Yongyou Zhu, Aihui Ma, et al.. (2023). The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling. Breast Cancer Research. 25(1). 144–144. 3 indexed citations

Wu, Feinan, Brian Magnuson, Elise R. Pfaltzgraff, et al.. (2022). EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma. Clinical Cancer Research. 28(20). 4466–4478. 16 indexed citations

Magnuson, Brian, Karan Bedi, Bartlomiej Bartkowiak, et al.. (2022). CDK12 regulates co-transcriptional splicing and RNA turnover in human cells. iScience. 25(9). 105030–105030. 13 indexed citations

Bedi, Karan, et al.. (2021). Cotranscriptional splicing efficiencies differ within genes and between cell types. RNA. 27(7). 829–840. 17 indexed citations

Sasaki, Takayo, Juan Carlos Rivera‐Mulia, Brian Magnuson, et al.. (2020). 3D genome organization contributes to genome instability at fragile sites. Nature Communications. 11(1). 3613–3613. 50 indexed citations

McCool, Kevin W., Zachary T. Freeman, Yali Zhai, et al.. (2019). Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts. Cancer Research. 80(4). 877–889. 17 indexed citations

10.

Kazyken, Dubek, Brian Magnuson, Çağrı Bodur, et al.. (2019). AMPK directly activates mTORC2 to promote cell survival during acute energetic stress. Science Signaling. 12(585). 175 indexed citations

11.

Palmbos, Phillip L., Yin Wang, Armand Bankhead, et al.. (2019). ATDC mediates a TP63-regulated basal cancer invasive program. Oncogene. 38(18). 3340–3354. 16 indexed citations

12.

Abel, Ethan V., Masashi Goto, Brian Magnuson, et al.. (2018). HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties. eLife. 7. 53 indexed citations

13.

Paulsen, Michelle T., Karan Bedi, Nathaniel K. Berg, et al.. (2017). Transcriptional and post-transcriptional regulation of the ionizing radiation response by ATM and p53. Scientific Reports. 7(1). 43598–43598. 31 indexed citations

14.

Magnuson, Brian, Karan Bedi, & Mats Ljungman. (2016). Genome stability versus transcript diversity. DNA repair. 44. 81–86. 8 indexed citations

15.

Magnuson, Brian, Artur Veloso, Killeen S. Kirkconnell, et al.. (2015). Identifying transcription start sites and active enhancer elements using BruUV-seq. Scientific Reports. 5(1). 17978–17978. 23 indexed citations

16.

Svoboda, Laurie K., Ashley Harris, Raphaela Schwentner, et al.. (2014). Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs. Epigenetics. 9(12). 1613–1625. 51 indexed citations

17.

Veloso, Artur, Killeen S. Kirkconnell, Brian Magnuson, et al.. (2014). Rate of elongation by RNA polymerase II is associated with specific gene features and epigenetic modifications. Genome Research. 24(6). 896–905. 206 indexed citations

18.

Veloso, Artur, Michelle T. Paulsen, Nathan Berg, et al.. (2013). Correction: Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin. PLoS ONE. 8(12). 15 indexed citations

19.

Veloso, Artur, Michelle T. Paulsen, Nathaniel K. Berg, et al.. (2013). Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin. PLoS ONE. 8(10). e78190–e78190. 31 indexed citations

20.

Paulsen, Michelle T., Artur Veloso, Jayendra Prasad, et al.. (2013). Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA. Methods. 67(1). 45–54. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact